APA
Matsuo E., Miyazaki Y., Tsutsumi C., Inoue Y., Yamasaki R., Hata T., Fukushima T., Tsushima H., Imanishi D., Imaizumi Y., Iwanaga M., Sakai M., Ando K., Sawayama Y., Ogawa D., Kawaguchi Y., Nagai K., Tsukasaki K., Ikeda S., Moriuchi Y., Yoshida S., Honda M., Taguchi J., Onimaru Y., Tsuchiya T., Tawara M., Atogami S., Yamamura M., Soda H., Yoshida Y., Matsuo Y., Nonaka H., Joh T., Takasaki Y., Kawasaki C., Momita S., Jinnai I., Kuriyama K. & Tomonaga M. (20070509). Imatinib provides durable molecular and cytogenetic responses in a practical setting for both newly diagnosed and previously treated chronic myelogenous leukemia: a study in nagasaki prefecture, Japan. : International journal of hematology.
Chicago
Matsuo Emi, Miyazaki Yasushi, Tsutsumi Chizuko, Inoue Yoriko, Yamasaki Reishi, Hata Tomoko, Fukushima Takuya, Tsushima Hideki, Imanishi Daisuke, Imaizumi Yoshitaka, Iwanaga Masako, Sakai Mari, Ando Koji, Sawayama Yasushi, Ogawa Daisuke, Kawaguchi Yasuhisa, Nagai Kazuhiro, Tsukasaki Kunihiro, Ikeda Shuichi, Moriuchi Yukiyoshi, Yoshida Shinichiro, Honda Miyuki, Taguchi Jun, Onimaru Yasuyuki, Tsuchiya Takeshi, Tawara Masayuki, Atogami Sunao, Yamamura Masaomi, Soda Hisashi, Yoshida Yoshiharu, Matsuo Yuji, Nonaka Hiroaki, Joh Tatsuro, Takasaki Yumi, Kawasaki Chiyuki, Momita Saburo, Jinnai Itsuro, Kuriyama Kazutaka and Tomonaga Masao. 20070509. Imatinib provides durable molecular and cytogenetic responses in a practical setting for both newly diagnosed and previously treated chronic myelogenous leukemia: a study in nagasaki prefecture, Japan. : International journal of hematology.
Harvard
Matsuo E., Miyazaki Y., Tsutsumi C., Inoue Y., Yamasaki R., Hata T., Fukushima T., Tsushima H., Imanishi D., Imaizumi Y., Iwanaga M., Sakai M., Ando K., Sawayama Y., Ogawa D., Kawaguchi Y., Nagai K., Tsukasaki K., Ikeda S., Moriuchi Y., Yoshida S., Honda M., Taguchi J., Onimaru Y., Tsuchiya T., Tawara M., Atogami S., Yamamura M., Soda H., Yoshida Y., Matsuo Y., Nonaka H., Joh T., Takasaki Y., Kawasaki C., Momita S., Jinnai I., Kuriyama K. and Tomonaga M. (20070509). Imatinib provides durable molecular and cytogenetic responses in a practical setting for both newly diagnosed and previously treated chronic myelogenous leukemia: a study in nagasaki prefecture, Japan. : International journal of hematology.
MLA
Matsuo Emi, Miyazaki Yasushi, Tsutsumi Chizuko, Inoue Yoriko, Yamasaki Reishi, Hata Tomoko, Fukushima Takuya, Tsushima Hideki, Imanishi Daisuke, Imaizumi Yoshitaka, Iwanaga Masako, Sakai Mari, Ando Koji, Sawayama Yasushi, Ogawa Daisuke, Kawaguchi Yasuhisa, Nagai Kazuhiro, Tsukasaki Kunihiro, Ikeda Shuichi, Moriuchi Yukiyoshi, Yoshida Shinichiro, Honda Miyuki, Taguchi Jun, Onimaru Yasuyuki, Tsuchiya Takeshi, Tawara Masayuki, Atogami Sunao, Yamamura Masaomi, Soda Hisashi, Yoshida Yoshiharu, Matsuo Yuji, Nonaka Hiroaki, Joh Tatsuro, Takasaki Yumi, Kawasaki Chiyuki, Momita Saburo, Jinnai Itsuro, Kuriyama Kazutaka and Tomonaga Masao. Imatinib provides durable molecular and cytogenetic responses in a practical setting for both newly diagnosed and previously treated chronic myelogenous leukemia: a study in nagasaki prefecture, Japan. : International journal of hematology. 20070509.